Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-007307
Filing Date
2018-03-13
Accepted
2018-03-13 18:11:20
Documents
1
Period of Report
2018-03-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6545
  Complete submission text file 0000899243-18-007307.txt   8164
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
LOVE TED W (Reporting) CIK: 0001188919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 18687799

Mailing Address 3101 WESTERN AVE. SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVE. SUITE 600 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Issuer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research